Source: Scientific reports. Unidade: FM
Subjects: REVISÃO SISTEMÁTICA, METANÁLISE, ARTRITE REUMATOIDE, FÁRMACOS ANTIRREUMÁTICOS
ABNT
ASCEF, Bruna de Oliveira et al. Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis. Scientific reports, v. 13, n. 13699, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57499. Acesso em: 19 nov. 2024.APA
Ascef, B. de O., Almeida, M. O., Medeiros-Ribeiro, A. C. de, Andrade, D. C. de O., Oliveira Junior, H. A. de, & Soarez, P. C. D. (2023). Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis. Scientific reports, 13( 13699). doi:10.1038/s41598-023-40222-5NLM
Ascef B de O, Almeida MO, Medeiros-Ribeiro AC de, Andrade DC de O, Oliveira Junior HA de, Soarez PCD. Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis [Internet]. Scientific reports. 2023 ; 13( 13699):[citado 2024 nov. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57499Vancouver
Ascef B de O, Almeida MO, Medeiros-Ribeiro AC de, Andrade DC de O, Oliveira Junior HA de, Soarez PCD. Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis [Internet]. Scientific reports. 2023 ; 13( 13699):[citado 2024 nov. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57499